ARTICLE | Company News
MorphoSys, Temple University deal
May 12, 2014 7:00 AM UTC
The university's Moulder Center for Drug Discovery Research unit will use MorphoSys' Ylanthia antibody technology to validate new targets and generate antibodies. MorphoSys will have an exclusive opti...